Chapter 4

The Development and Clinical Progress on Chemokine Receptor-Based HIV Entry Inhibitors

Yi-Qun Kuang

Abstract

Entry of HIV-1 into targeted host cells is a highly ordered multistage process involving first-receptor attachment, co-receptor binding, and membrane fusion. In this chapter, I will present an overview of progress on HIV-1 entry inhibitors with a focus on chemokine receptor-based antagonists. This chapter, at first, will describe the working mechanisms of chemokine receptors, HIV-1 co-receptors CCR5 and CXCR4, during the replication procedure. Then, the antagonists-based on different mechanisms will be presented in detail. At last, it will summarize and explain the distinct promising entry inhibitors based on co-receptors-interacting proteins, which is inspired by our current work.

Total Pages: 105-137 (33)

Purchase Chapter  Book Details

RELATED BOOKS

.Drug Addiction Mechanisms in the Brain.
.Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems.
.Software and Programming Tools in Pharmaceutical Research.
.Objective Pharmaceutics: A Comprehensive Compilation of Questions and Answers for Pharmaceutics Exam Prep.
.COVID 19 – Monitoring with IoT Devices.
.Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents.
.Recent Trends and The Future of Antimicrobial Agents - Part 2.
.COVID-19: Origin, Impact and Management (Part 1).